Noncanonical TGF-β signaling during mammary tumorigenesis

Journal of Mammary Gland Biology and Neoplasia

Volumn 16, Issue 2, 2011, Pages 127-146

  Parvani, Jenny G ^a   Taylor, Molly A ^a   Schiemann, William P ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Epithelial mesenchymal transition; Metastasis; Signal transduction; Transforming growth factor ; Tumor microenvironment

Indexed keywords

COLLAGEN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; FOCAL ADHESION KINASE; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; PROTEIN LYSINE 6 OXIDASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCATTER FACTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CELL PROLIFERATION; CYTOPLASM; CYTOSTASIS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; METAMORPHOSIS; METASTASIS; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL EXPANSION; TIGHT JUNCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79959524843     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-011-9207-3     Document Type: Review

References (254)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin 60 5 277 300 20610543
2. DX Nguyen PD Bos J Massague 2009 Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 9 4 274 284 19308067 1:CAS:528:DC%2BD1MXjsFSrsr4%3D
3. DX Nguyen J Massague 2007 Genetic determinants of cancer metastasis Nat Rev Genet 8 5 341 352 17440531 1:CAS:528:DC%2BD2sXktlSltLc%3D (Pubitemid 46625811)
4. J Yang RA Weinberg 2008 Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14 6 818 829 18539112 1:CAS:528:DC%2BD1cXnsVCrs7g%3D (Pubitemid 351757205)
5. MA Taylor JG Parvani WP Schiemann 2010 The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-β in normal and malignant mammary epithelial cells J Mammary Gland Biol Neoplasia 15 2 169 190 20467795
6. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminous R, Waldron W, et al. SEER Cancer Statistics Review 1975-1007. National Cancer Institute. 2010.
7. H Kennecke R Yerushalmi R Woods MC Cheang D Voduc CH Speers, et al. 2010 Metastatic behavior of breast cancer subtypes J Clin Oncol 28 20 3271 3277 20498394
8. AC Chiang J Massague 2008 Molecular basis of metastasis N Engl J Med 359 26 2814 2823 19109576 1:CAS:528:DC%2BD1cXhsFCnt7bF
9. AF Chambers AC Groom IC MacDonald 2002 Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 8 563 572 12154349 1:CAS:528:DC%2BD38XlslGqsLw%3D (Pubitemid 37328923)
10. D Weinstat-Saslow PS Steeg 1994 Angiogenesis and colonization in the tumor metastatic process: basic and applied advances FASEB J 8 6 401 407 7513289 1:CAS:528:DyaK2cXivFGgsL0%3D (Pubitemid 24155952)
11. C Scheel T Onder A Karnoub RA Weinberg 2007 Adaptation versus selection: the origins of metastatic behavior Cancer Res 67 24 11476 11479 18089773 1:CAS:528:DC%2BD2sXhsVCjs7zL
12. JE Talmadge 2007 Clonal selection of metastasis within the life history of a tumor Cancer Res 67 24 11471 11475 18089772 1:CAS:528:DC%2BD2sXhsVCjs7zK
13. JE Talmadge IJ Fidler 2010 AACR centennial series: the biology of cancer metastasis: historical perspective Cancer Res 70 14 5649 5669 20610625 1:CAS:528:DC%2BC3cXovVantLY%3D
14. Spratt JS, Spratt JA. Growth rates. In: Donegan WL editor. Cancer of the Breast. Spratt, J.S.; 2002. p. 443-476.
15. GP Gupta J Massague 2006 Cancer metastasis: building a framework Cell 127 4 679 695 17110329 1:CAS:528:DC%2BD28Xht1yqs7rL (Pubitemid 44781029)
16. F Li B Tiede J Massague Y Kang 2007 Beyond tumorigenesis: cancer stem cells in metastasis Cell Res 17 1 3 14 17179981 1:CAS:528:DC%2BD2sXkslerug%3D%3D (Pubitemid 46096419)
17. R Serra MR Crowley 2003 TGF-β in mammary gland development and breast cancer Breast Dis 18 61 73 15687689 1:CAS:528:DC%2BD2cXlvVehur4%3D (Pubitemid 39193332)
18. R Serra MR Crowley 2005 Mouse models of transforming growth factor β impact in breast development and cancer Endocr Relat Cancer. 12 4 749 760 16322320 1:CAS:528:DC%2BD28XnvVOquw%3D%3D (Pubitemid 41815774)
19. M Tian WP Schiemann 2009 The TGF-β paradox in human cancer: an update Future Oncol 5 2 259 271 19284383 1:CAS:528:DC%2BD1MXjtlOrurY%3D
20. MH Barcellos-Hoff RJ Akhurst 2009 Transforming growth factor-β in breast cancer: too much, too late Breast Cancer Res 11 1 202 19291273
21. Tian M, Neil JR, Schiemann WP. Transforming growth factor-β and the hallmarks of cancer. Cell Signal. 2010; PMID: 20940046.
22. B Bierie HL Moses 2006 Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer Nat Rev Cancer 6 7 506 520 16794634 1:CAS:528:DC%2BD28XmtFegsr4%3D (Pubitemid 43980540)
23. RA Rahimi EB Leof 2007 TGF-β signaling: a tale of two responses J Cell Biochem 102 3 593 608 17729308 1:CAS:528:DC%2BD2sXht1SjsbnP (Pubitemid 47557414)
24. WP Schiemann 2007 Targeted TGF-β chemotherapies: friend or foe in treating human malignancies? Expert Rev Anticancer Ther 7 5 609 611 17492924 1:CAS:528:DC%2BD2sXmvVKqs7w%3D (Pubitemid 46805559)
25. SV Sharma DY Lee B Li MP Quinlan F Takahashi S Maheswaran, et al. 2010 A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations Cell 141 1 69 80 20371346 1:CAS:528:DC%2BC3cXlsVSgtb8%3D
26. JH Taube JI Herschkowitz K Komurov AY Zhou S Gupta J Yang, et al. 2010 Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes Proc Natl Acad Sci USA 107 35 15449 15454 20713713 1:CAS:528:DC%2BC3cXhtFaqurfK
27. CJ Creighton X Li M Landis JM Dixon VM Neumeister A Sjolund, et al. 2009 Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Proc Natl Acad Sci USA 106 33 13820 13825 19666588 1:CAS:528:DC%2BD1MXhtFWksLjF
28. P Farmer H Bonnefoi P Anderle D Cameron P Wirapati V Becette, et al. 2009 A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer Nat Med 15 1 68 74 19122658 1:CAS:528:DC%2BD1MXhtVyjsQ%3D%3D
29. SA Mani W Guo MJ Liao EN Eaton A Ayyanan AY Zhou, et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 4 704 715 18485877 1:CAS:528:DC%2BD1cXmsVOru7w%3D (Pubitemid 351636299)
30. M Shipitsin LL Campbell P Argani S Weremowicz N Bloushtain-Qimron J Yao, et al. 2007 Molecular definition of breast tumor heterogeneity Cancer Cell 11 3 259 273 17349583 1:CAS:528:DC%2BD2sXjsVymtL0%3D (Pubitemid 46349843)
31. A Albini MB Sporn 2007 The tumour microenvironment as a target for chemoprevention Nat Rev Cancer 7 2 139 147 17218951 1:CAS:528: DC%2BD2sXotFOjuw%3D%3D (Pubitemid 46160989)
32. GC Blobe WP Schiemann HF Lodish 2000 Role of transforming growth factor β in human disease N Engl J Med 342 18 1350 1358 10793168 1:CAS:528:DC%2BD3cXjtlyksrY%3D (Pubitemid 30408720)
33. J Massague 1998 TGF-β signal transduction Annu Rev Biochem 67 753 791 9759503 1:CAS:528:DyaK1cXlsFOmsbY%3D
34. H Chang CW Brown MM Matzuk 2002 Genetic analysis of the mammalian transforming growth factor-β superfamily Endocr Rev 23 6 787 823 12466190 1:CAS:528:DC%2BD38XpvVSntLc%3D (Pubitemid 35454589)
35. SL Nishimura 2009 Integrin-mediated transforming growth factor-β activation, a potential therapeutic target in fibrogenic disorders Am J Pathol 175 4 1362 1370 19729474 1:CAS:528:DC%2BD1MXhtlWitbfN
36. DB Rifkin 2005 Latent transforming growth factor-β (TGF-β) binding proteins: orchestrators of TGF-β availability J Biol Chem 280 9 7409 7412 15611103 1:CAS:528:DC%2BD2MXhs1yju7Y%3D (Pubitemid 40349631)
37. J Massague RR Gomis 2006 The logic of TGFβ signaling FEBS Lett 580 12 2811 2820 16678165 1:CAS:528:DC%2BD28XltVKntrg%3D
38. J Massague J Seoane D Wotton 2005 Smad transcription factors Genes Dev 19 23 2783 2810 16322555 1:CAS:528:DC%2BD2MXhtlWqsrnI (Pubitemid 41739965)
39. T Tsukazaki TA Chiang AF Davison L Attisano JL Wrana 1998 SARA, a FYVE domain protein that recruits Smad2 to the TGFβreceptor Cell 95 6 779 791 9865696 1:CAS:528:DyaK1MXivVKj (Pubitemid 29014458)
40. S Miura T Takeshita H Asao Y Kimura K Murata Y Sasaki, et al. 2000 Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA Mol Cell Biol 20 24 9346 9355 11094085 1:CAS:528:DC%2BD3MXivValsrg%3D (Pubitemid 32246119)
41. N Faresse F Colland N Ferrand C Prunier MF Bourgeade A Atfi 2008 Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-β signalling EMBO J 27 13 1804 1815 18511908 1:CAS:528: DC%2BD1cXot1emsLs%3D (Pubitemid 351960206)
42. BA Hocevar A Smine XX Xu PH Howe 2001 The adaptor molecule Disabled-2 links the transforming growth factor β receptors to the Smad pathway EMBO J 20 11 2789 2801 11387212 1:CAS:528:DC%2BD3MXksFGrsbk%3D (Pubitemid 32938562)
43. SG Penheiter RD Singh CE Repellin MC Wilkes M Edens PH Howe, et al. 2010 Type II transforming growth factor-β receptor recycling is dependent upon the clathrin adaptor protein Dab2 Mol Biol Cell 21 22 4009 4019 20881059 1:CAS:528:DC%2BC3cXhsFagsrfI
44. CE Runyan T Hayashida S Hubchak JF Curley HW Schnaper 2009 Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype J Biol Chem 284 37 25181 25189 19620243 1:CAS:528:DC%2BD1MXhtV2nsb7P
45. A Chaudhury GS Hussey PS Ray G Jin PL Fox PH Howe 2010 TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI Nat Cell Biol 12 3 286 293 20154680 1:CAS:528:DC%2BC3cXisFems7w%3D
46. BA Hocevar C Prunier PH Howe 2005 Disabled-2 (Dab2) mediates transforming growth factor β (TGFβ)-stimulated fibronectin synthesis through TGFβ-activated kinase 1 and activation of the JNK pathway J Biol Chem 280 27 25920 25927 15894542 1:CAS:528:DC%2BD2MXlslyksb0%3D (Pubitemid 40962305)
47. GS Hussey A Chaudhury AE Dawson DJ Lindner CR Knudsen MC Wilce, et al. 2011 Identification of an mRNP complex regulating tumorigenesis at the translational elongation step Mol Cell 41 4 419 431 21329880 1:CAS:528:DC%2BC3MXit1GgsLY%3D
48. W Kim Y Seok Kang J Soo Kim NY Shin SK Hanks WK Song 2008 The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-β signaling Mol Biol Cell 19 5 2135 2146 18321991 1:CAS:528:DC%2BD1cXlslelsLk%3D
49. MK Wendt JA Smith WP Schiemann 2009 p130Cas is required for mammary tumor growth and transforming growth factor-β-mediated metastasis through regulation of Smad2/3 activity J Biol Chem 284 49 34145 34156 19822523 1:CAS:528:DC%2BD1MXhsVymu7bJ
50. H Hayashi S Abdollah Y Qiu J Cai YY Xu BW Grinnell, et al. 1997 The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling Cell 89 1165 1173 9215638 1:CAS:528:DyaK2sXkt1Kks70%3D (Pubitemid 127678749)
51. A Nakao M Afrakht A Moren T Nakayama JL Christian R Heuchel, et al. 1997 Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling Nature 389 631 635 9335507 1:CAS:528:DyaK2sXmslWksrs%3D (Pubitemid 27446184)
52. S Souchelnytskyi T Nakayama A Nakao A Moren CH Heldin JL Christian, et al. 1998 Physical and functional interaction of murine and xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-β receptors J Biol Chem 273 25364 25370 9738003 1:CAS:528:DyaK1cXmsVGmu7w%3D (Pubitemid 28443303)
53. T Ebisawa M Fukuchi G Murakami T Chiba K Tanaka T Imamura, et al. 2001 Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation J Biol Chem 276 16 12477 12480 11278251 1:CAS:528:DC%2BD3MXjtFynsbk%3D
54. P Kavsak RK Rasmussen CG Causing S Bonni H Zhu GH Thomsen, et al. 2000 Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation Mol Cell 6 6 1365 1375 11163210 1:CAS:528: DC%2BD3MXlvFahug%3D%3D (Pubitemid 32045929)
55. PK Datta HL Moses 2000 STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling Mol Cell Biol 20 9 3157 3167 10757800 1:CAS:528:DC%2BD3cXivFSku7w%3D (Pubitemid 30215028)
56. N Ibarrola I Kratchmarova D Nakajima WP Schiemann A Moustakas A Pandey, et al. 2004 Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor β signaling BMC Cell Biol 5 2 14728725
57. D Koinuma M Shinozaki A Komuro K Goto M Saitoh A Hanyu, et al. 2003 Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7 EMBO J 22 24 6458 6470 14657019 1:CAS:528:DC%2BD3sXpvVemtL0%3D (Pubitemid 38009594)
58. X Lin X Duan YY Liang Y Su KH Wrighton J Long, et al. 2006 PPM1A functions as a Smad phosphatase to terminate TGFβ signaling Cell 125 5 915 928 16751101 1:CAS:528:DC%2BD28Xls1Shtrw%3D (Pubitemid 43795197)
59. X Lin M Liang XH Feng 2000 Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling J Biol Chem 275 47 36818 36822 11016919 1:CAS:528:DC%2BD3cXoslWls74%3D (Pubitemid 32002092)
60. RS Lo J Massague 1999 Ubiquitin-dependent degradation of TGF-β-activated Smad2 Nat Cell Biol 1 8 472 478 10587642 1:CAS:528:DyaK1MXotFaltbg%3D
61. M Fukuchi T Imamura T Chiba T Ebisawa M Kawabata K Tanaka, et al. 2001 Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins Mol Biol Cell 12 5 1431 1443 11359933 1:CAS:528: DC%2BD3MXjslWhsbY%3D (Pubitemid 33044422)
62. L Izzi L Attisano 2004 Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation Oncogene 23 11 2071 2078 15021894 1:CAS:528:DC%2BD2cXitVOis7w%3D (Pubitemid 38496736)
63. S Dupont A Mamidi M Cordenonsi M Montagner L Zacchigna M Adorno, et al. 2009 FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination Cell 136 1 123 135 19135894 1:CAS:528:DC%2BD1MXhtFOitr4%3D
64. R Derynck RJ Akhurst A Balmain 2001 TGF-β signaling in tumor suppression and cancer progression Nat Genet 29 2 117 129 11586292 1:CAS:528:DC%2BD3MXnsFKgt7c%3D (Pubitemid 32952643)
65. J Massague 2008 TGFβ in cancer Cell 134 2 215 230 18662538 1:CAS:528:DC%2BD1cXptlaltbk%3D
66. R Derynck RJ Akhurst 2007 Differentiation plasticity regulated by TGF-β family proteins in development and disease Nat Cell Biol 9 9 1000 1004 17762890 1:CAS:528:DC%2BD2sXpslGju7k%3D (Pubitemid 47338137)
67. E Piek A Moustakas A Kurisaki CH Heldin P ten Dijke 1999 TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells J Cell Sci 112 4557 4568 10574705 1:CAS:528:DC%2BD3cXntlGisQ%3D%3D (Pubitemid 30034805)
68. U Valcourt M Kowanetz H Niimi CH Heldin A Moustakas 2005 TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition Mol Biol Cell 16 4 1987 2002 15689496 1:CAS:528:DC%2BD2MXjt1KqtbY%3D (Pubitemid 40471965)
69. MK Wendt TM Allington WP Schiemann 2009 Mechanisms of the epithelial-mesenchymal transition by TGF-β Future Oncol 5 8 1145 1168 19852727 1:CAS:528:DC%2BD1MXhtleisb%2FP
70. M Oft RJ Akhurst A Balmain 2002 Metastasis is driven by sequential elevation of H-Ras and Smad2 levels Nat Cell Biol 4 7 487 494 12105419 1:CAS:528:DC%2BD38Xmt1Kmu7c%3D (Pubitemid 34752433)
71. K Lehmann E Janda CE Pierreux M Rytomaa A Schulze M McMahon, et al. 2000 Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells Genes Dev 14 20 2610 2622 11040215 1:CAS:528:DC%2BD3cXnslGru7s%3D
72. JR Neil KM Johnson RA Nemenoff WP Schiemann 2008 Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-β through a PGE2-dependent mechanisms Carcinogenesis 29 11 2227 2235 18725385 1:CAS:528:DC%2BD1cXhtlalsLjE
73. JR Neil WP Schiemann 2008 Altered TAB1:IκB kinase interaction promotes transforming growth factor β-mediated nuclear factor-κB activation during breast cancer progression Cancer Res 68 5 1462 1470 18316610 1:CAS:528:DC%2BD1cXislagu7w%3D (Pubitemid 351346854)
74. JR Neil M Tian WP Schiemann 2009 x-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-β-mediated nuclear factor-κB activation during breast cancer progression J Biol Chem 284 32 21209 21217 19531477 1:CAS:528:DC%2BD1MXpt1Wjurs%3D
75. M Tian WP Schiemann 2010 PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-β signaling during mammary tumorigenesis FASEB J 24 4 1105 1116 19897661 1:CAS:528:DC%2BC3cXktlOqsbw%3D
76. M Kretzschmar J Doody I Timokhina J Massague 1999 A mechanism of repression of TGFβ/ Smad signaling by oncogenic Ras Genes Dev 13 7 804 816 10197981 1:CAS:528:DyaK1MXisF2isrg%3D (Pubitemid 29169840)
77. M Funaba CM Zimmerman LS Mathews 2002 Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase J Biol Chem 277 44 41361 41368 12193595 1:CAS:528:DC%2BD38XotF2htb4%3D (Pubitemid 35257436)
78. JD Brown MR DiChiara KR Anderson MA Gimbrone Jr JN Topper 1999 MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells J Biol Chem 274 13 8797 8805 10085121 1:CAS:528:DyaK1MXitFyrt7Y%3D (Pubitemid 29164678)
79. ME Engel MA McDonnell BK Law HL Moses 1999 Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription J Biol Chem 274 52 37413 37420 10601313 1:CAS:528:DC%2BD3cXpsFCg
80. DS Waddell NT Liberati X Guo JP Frederick XF Wang 2004 Casein kinase Iepsilon plays a functional role in the transforming growth factor-β signaling pathway J Biol Chem 279 28 29236 29246 15133026 1:CAS:528: DC%2BD2cXlsVCmsL8%3D (Pubitemid 38915799)
81. I Yakymovych P Ten Dijke CH Heldin S Souchelnytskyi 2001 Regulation of Smad signaling by protein kinase C FASEB J 15 3 553 555 11259364 1:CAS:528:DC%2BD3MXitFWmsr4%3D
82. SJ Wicks S Lui N Abdel-Wahab RM Mason A Chantry 2000 Inactivation of smad-transforming growth factor β signaling by Ca(2+)-calmodulin-dependent protein kinase II Mol Cell Biol 20 21 8103 8111 11027280 1:CAS:528: DC%2BD3cXnslOjtrw%3D
83. X Guo A Ramirez DS Waddell Z Li X Liu XF Wang 2008 Axin and GSK3βcontrol Smad3 protein stability and modulate TGF-βsignaling Genes Dev 22 1 106 120 18172167 1:CAS:528:DC%2BD1cXks1Snug%3D%3D
84. TM Allington AJ Galliher-Beckley WP Schiemann 2009 Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors FASEB J 23 12 4231 4243 19690215 1:CAS:528: DC%2BD1MXhsFCgur%2FF
85. AJ Galliher WP Schiemann 2006 β3 integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells Breast Cancer Res 8 4 R42 16859511
86. AJ Galliher WP Schiemann 2007 Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion Cancer Res 67 8 3752 3758 17440088 1:CAS:528:DC%2BD2sXkt1Kitro%3D (Pubitemid 46762161)
87. AJ Galliher-Beckley WP Schiemann 2008 Grb2 binding to Tyr284 in TβR-II is essential for mammary tumor growth and metastasis stimulated by TGF-β Carcinogenesis 29 2 244 251 18174260 1:CAS:528:DC%2BD1cXislKhtr0%3D (Pubitemid 351359662)
88. MK Wendt WP Schiemann 2009 Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis Breast Cancer Res 11 5 R68 19740433
89. MK Wendt JA Smith WP Schiemann 2010 Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression Oncogene 29 49 6485 6498 20802523 1:CAS:528:DC%2BC3cXhtVyqsL7O
90. Taylor MA, Amin J, Kirschmann DA, Schiemann WP. Lysyl oxidase and hydrogen peroxide promote oncogenic signaling by transforming growth factor-βin mammary epithelial cells. Neoplasia. 2011;13:in press.
91. YH Lee AR Albig M Regner BJ Schiemann WP Schiemann 2008 Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-βin mammary epithelial cells via a MMP-dependent mechanism Carcinogenesis 29 12 2243 2251 18713838 1:CAS:528:DC%2BD1cXhsVOgsLfO
92. A Moustakas CH Heldin 2005 Non-Smad TGF-βsignals J Cell Sci 118 Pt 16 3573 3584 16105881 1:CAS:528:DC%2BD2MXhtVaktrvK
93. JS Kang C Liu R Derynck 2009 New regulatory mechanisms of TGF-β receptor function Trends Cell Biol 19 8 385 394 19648010 1:CAS:528: DC%2BD1MXhtVSitLjF
94. JS Desgrosellier DA Cheresh 2010 Integrins in cancer: biological implications and therapeutic opportunities Nat Rev Cancer 10 1 9 22 20029421 1:CAS:528:DC%2BD1MXhsF2hsLzI
95. M Egeblad ES Nakasone Z Werb 2010 Tumors as organs: complex tissues that interface with the entire organism Dev Cell 18 6 884 901 20627072 1:CAS:528:DC%2BC3cXos1Kqtrk%3D
96. MM Zutter 2007 Integrin-mediated adhesion: tipping the balance between chemosensitivity and chemoresistance Adv Exp Med Biol 608 87 100 17993234 1:CAS:528:DC%2BC3cXhtlKgsb7F
97. JS Munger X Huang H Kawakatsu MJ Griffiths SL Dalton J Wu, et al. 1999 The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis Cell 96 3 319 328 10025398 1:CAS:528:DyaK1MXht1eqsrY%3D (Pubitemid 29077586)
98. D Mu S Cambier L Fjellbirkeland JL Baron JS Munger H Kawakatsu, et al. 2002 The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1 J Cell Biol 157 3 493 507 11970960 1:CAS:528:DC%2BD38XjtleltLk%3D (Pubitemid 34839812)
99. EK Sloan N Pouliot KL Stanley J Chia JM Moseley DK Hards, et al. 2006 Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone Breast Cancer Res 8 2 R20 16608535
100. A Bandyopadhyay JK Agyin L Wang Y Tang X Lei BM Story, et al. 2006 Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor Cancer Res 66 13 6714 6721 16818646 1:CAS:528:DC%2BD28XmsVamu7o%3D (Pubitemid 44085629)
101. N Garamszegi SP Garamszegi P Samavarchi-Tehrani E Walford MM Schneiderbauer JL Wrana, et al. 2010 Extracellular matrix-induced transforming growth factor-β receptor signaling dynamics Oncogene 29 16 2368 2380 20101206 1:CAS:528:DC%2BC3cXltVGhtbc%3D
102. S van der Flier CM Chan A Brinkman M Smid SR Johnston LC Dorssers, et al. 2000 BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas Int J Cancer 89 5 465 468 11008210
103. HQ Ta KS Thomas RS Schrecengost AH Bouton 2008 A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells Cancer Res 68 21 8796 8804 18974122 1:CAS:528: DC%2BD1cXhtlSkur7I
104. S Cabodi A Tinnirello B Bisaro G Tornillo M del Pilar Camacho-Leal G Forni, et al. 2010 p130Cas is an essential transducer element in ErbB2 transformation FASEB J 24 10 3796 3808 20505116 1:CAS:528:DC%2BC3cXht12isLfI
105. S Cabodi A Tinnirello P Di Stefano B Bisaro E Ambrosino I Castellano, et al. 2006 p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis Cancer Res 66 9 4672 4680 16651418 1:CAS:528:DC%2BD28XjvF2ksbo%3D
106. NA Bhowmick R Zent M Ghiassi M McDonnell HL Moses 2001 Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity J Biol Chem 276 50 46707 46713 11590169 1:CAS:528:DC%2BD3MXpt1Gns7g%3D
107. GJ Mizejewski 1999 Role of integrins in cancer: survey of expression patterns Proc Soc Exp Biol Med 222 2 124 138 10564536 1:CAS:528: DyaK1MXntFCgtr4%3D
108. VM Weaver S Lelievre JN Lakins MA Chrenek JC Jones F Giancotti, et al. 2002 β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium Cancer Cell 2 3 205 216 12242153 1:CAS:528:DC%2BD38Xnt1yhtbc%3D (Pubitemid 41043976)
109. JA Engelman 2009 Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nat Rev Cancer 9 8 550 562 19629070 1:CAS:528:DC%2BD1MXovFylsrg%3D
110. AV Bakin AK Tomlinson NA Bhowmick HL Moses CL Arteaga 2000 Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration J Biol Chem 275 47 36803 36810 10969078 1:CAS:528:DC%2BD3cXoslWlsrY%3D (Pubitemid 32002090)
111. MM Murillo G del Castillo A Sanchez M Fernandez I Fabregat 2005 Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes Oncogene 24 28 4580 4587 15856020 1:CAS:528:DC%2BD2MXls1Onu7o%3D (Pubitemid 41032621)
112. M Jechlinger A Sommer R Moriggl P Seither N Kraut P Capodiecci, et al. 2006 Autocrine PDGFR signaling promotes mammary cancer metastasis J Clin Invest 116 6 1561 1570 16741576 1:CAS:528:DC%2BD28XlsFWrtbc%3D
113. S Uttamsingh X Bao KT Nguyen M Bhanot J Gong JL Chan, et al. 2008 Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells Oncogene 27 18 2626 2634 17982486 1:CAS:528:DC%2BD1cXkvVSit70%3D (Pubitemid 351550880)
114. S Lamouille R Derynck 2007 Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway J Cell Biol 178 3 437 451 17646396 1:CAS:528:DC%2BD2sXos1CrsLw%3D (Pubitemid 47196152)
115. AR Conery Y Cao EA Thompson CM Townsend Jr TC Ko K Luo 2004 Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis Nat Cell Biol 6 4 366 372 15104092 1:CAS:528:DC%2BD2cXis1Gltb8%3D (Pubitemid 38584827)
116. I Remy A Montmarquette SW Michnick 2004 PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3 Nat Cell Biol 6 4 358 365 15048128 1:CAS:528:DC%2BD2cXis1GltLY%3D (Pubitemid 38584826)
117. J Xu S Lamouille R Derynck 2009 TGF-β-induced epithelial to mesenchymal transition Cell Res 19 2 156 172 19153598 1:CAS:528: DC%2BD1MXht1amsL4%3D
118. CH Heldin M Landstrom A Moustakas 2009 Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition Curr Opin Cell Biol 21 2 166 176 19237272 1:CAS:528:DC%2BD1MXksVClurY%3D
119. A Hall 2005 Rho GTPases and the control of cell behaviour Biochem Soc Trans 33 Pt 5 891 895 16246005 1:CAS:528:DC%2BD2MXhtFCqs7zK (Pubitemid 41659073)
120. A Hall 2009 The cytoskeleton and cancer Cancer Metastasis Rev 28 1-2 5 14 19153674
121. NA Bhowmick M Ghiassi A Bakin M Aakre CA Lundquist ME Engel, et al. 2001 Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism Mol Biol Cell 12 1 27 36 11160820 1:CAS:528:DC%2BD3MXlvFKlsQ%3D%3D (Pubitemid 32060576)
122. AM Viloria-Petit L David JY Jia T Erdemir AL Bane D Pinnaduwage, et al. 2009 A role for the TGFβ-Par6 polarity pathway in breast cancer progression Proc Natl Acad Sci USA 106 33 14028 14033 19667198 1:CAS:528: DC%2BD1MXhtFWksL%2FP
123. B Ozdamar R Bose M Barrios-Rodiles HR Wang Y Zhang JL Wrana 2005 Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity Science 307 5715 1603 1609 15761148 1:CAS:528:DC%2BD2MXitV2isLs%3D (Pubitemid 40354739)
124. N Hutchison BM Hendry CC Sharpe 2009 Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells Cell Signal 21 10 1522 1531 19477269 1:CAS:528:DC%2BD1MXnvVWgt7w%3D
125. Y He JJ Northey M Primeau RD Machado R Trembath PM Siegel, et al. 2010 CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion Oncogene 30 9 1032 1045 21042277
126. K Mythreye GC Blobe 2009 The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42 Proc Natl Acad Sci USA 106 20 8221 8226 19416857 1:CAS:528:DC%2BD1MXmvVWmtrw%3D
127. W Kong H Yang L He JJ Zhao D Coppola WS Dalton, et al. 2008 MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA Mol Cell Biol 28 22 6773 6784 18794355 1:CAS:528:DC%2BD1cXhsVSnurfJ
128. S Valastyan N Benaich A Chang F Reinhardt RA Weinberg 2009 Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis Genes Dev 23 22 2592 2597 19875476 1:CAS:528:DC%2BD1MXhsVGrs73F
129. S Valastyan F Reinhardt N Benaich D Calogrias AM Szasz ZC Wang, et al. 2009 A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis Cell 137 6 1032 1046 19524507 1:CAS:528:DC%2BD1MXps1eiurY%3D
130. A Atfi S Djelloul E Chastre R Davis C Gespach 1997 Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling J Biol Chem 272 3 1429 1432 8999807 1:CAS:528:DyaK2sXls1ersw%3D%3D (Pubitemid 27043214)
131. AV Bakin C Rinehart AK Tomlinson CL Arteaga 2002 p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration J Cell Sci 115 Pt 15 3193 3206 12118074 1:CAS:528:DC%2BD38XmsFarsr4%3D
132. L Xie BK Law AM Chytil KA Brown ME Aakre HL Moses 2004 Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro Neoplasia 6 5 603 610 15548370 1:CAS:528:DC%2BD2cXhtVShu77P (Pubitemid 39411098)
133. Y Shintani MA Hollingsworth MJ Wheelock KR Johnson 2006 Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression Cancer Res 66 24 11745 11753 17178870 1:CAS:528:DC%2BD28Xhtlagu7%2FO (Pubitemid 46094186)
134. Y Shintani MJ Wheelock KR Johnson 2006 Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells Mol Biol Cell 17 7 2963 2975 16624865 1:CAS:528: DC%2BD28XmvVWktLc%3D (Pubitemid 43993501)
135. A Sorrentino N Thakur S Grimsby A Marcusson V von Bulow N Schuster, et al. 2008 The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner Nat Cell Biol 10 10 1199 1207 18758450 1:CAS:528:DC%2BD1cXhtFyqurrN
136. M Yamashita K Fatyol C Jin X Wang Z Liu YE Zhang 2008 TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β Mol Cell 31 6 918 924 18922473 1:CAS:528:DC%2BD1cXht1amsb%2FI
137. M Karin 2006 Nuclear factor-κB in cancer development and progression Nature 441 7092 431 436 16724054 1:CAS:528:DC%2BD28XkvVyrsrw%3D (Pubitemid 44050137)
138. MA Sovak M Arsura G Zanieski KT Kavanagh GE Sonenshein 1999 The inhibitory effects of transforming growth factor β1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-κB/Rel expression Cell Growth Differ 10 8 537 544 10470853 1:CAS:528:DyaK1MXlslWmtrs%3D (Pubitemid 29399061)
139. M Arsura M Wu GE Sonenshein 1996 TGF β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα Immunity 5 1 31 40 8758892 1:CAS:528:DyaK28Xks1Omtbo%3D (Pubitemid 26259622)
140. HJ You T How GC Blobe 2009 The type III transforming growth factor-β receptor negatively regulates nuclear factor κB signaling through its interaction with β-arrestin2 Carcinogenesis 30 8 1281 1287 19325136 1:CAS:528:DC%2BD1MXpsVakt78%3D
141. HL Chua P Bhat-Nakshatri SE Clare A Morimiya S Badve H Nakshatri 2007 NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 Oncogene 26 5 711 724 16862183 1:CAS:528:DC%2BD2sXhtFGmurs%3D (Pubitemid 46204250)
142. MA Huber N Azoitei B Baumann S Grunert A Sommer H Pehamberger, et al. 2004 NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J Clin Invest 114 4 569 581 15314694 1:CAS:528:DC%2BD2cXmvVelsrY%3D (Pubitemid 39572107)
143. HM Kagan W Li 2003 Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell J Cell Biochem 88 4 660 672 12577300 1:CAS:528:DC%2BD3sXhslWis7s%3D (Pubitemid 36258816)
144. SL Payne MJ Hendrix DA Kirschmann 2007 Paradoxical roles for lysyl oxidases in cancer-a prospect J Cell Biochem 101 6 1338 1354 17471532 1:CAS:528:DC%2BD2sXpt1agt7w%3D (Pubitemid 47242767)
145. MJ Paszek N Zahir KR Johnson JN Lakins GI Rozenberg A Gefen, et al. 2005 Tensional homeostasis and the malignant phenotype Cancer Cell 8 3 241 254 16169468 1:CAS:528:DC%2BD2MXhtV2gt7vO (Pubitemid 41317594)
146. KR Levental H Yu L Kass JN Lakins M Egeblad JT Erler, et al. 2009 Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 139 5 891 906 19931152 1:CAS:528:DC%2BC3cXksFWltQ%3D%3D
147. JT Erler KL Bennewith TR Cox G Lang D Bird A Koong, et al. 2009 Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche Cancer Cell 15 1 35 44 19111879 1:CAS:528:DC%2BD1MXptVGqug%3D%3D
148. JT Erler KL Bennewith M Nicolau N Dornhofer C Kong QT Le, et al. 2006 Lysyl oxidase is essential for hypoxia-induced metastasis Nature 440 7088 1222 1226 16642001 1:CAS:528:DC%2BD28XjvVGltb8%3D
149. SL Payne MJ Hendrix DA Kirschmann 2006 Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex J Cell Biochem 98 4 827 837 16440329 1:CAS:528:DC%2BD28XmsFyksLo%3D (Pubitemid 43993399)
150. L Yang J Huang X Ren AE Gorska A Chytil M Aakre, et al. 2008 Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+ CD11b+ myeloid cells that promote metastasis Cancer Cell 13 1 23 35 18167337 1:CAS:528: DC%2BD1cXnsVKnuw%3D%3D (Pubitemid 350309741)
151. A Moustakas CH Heldin 2007 Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression Cancer Sci 98 10 1512 1520 17645776 1:CAS:528:DC%2BD2sXhtF2qtb7J (Pubitemid 47308444)
152. E Tomaskovic-Crook EW Thompson JP Thiery 2009 Epithelial to mesenchymal transition and breast cancer Breast Cancer Res 11 6 213 19909494
153. R Kalluri RA Weinberg 2009 The basics of epithelial-mesenchymal transition J Clin Invest 119 6 1420 1428 19487818 1:CAS:528:DC%2BD1MXntVCjtr0%3D
154. D Padua XH Zhang Q Wang C Nadal WL Gerald RR Gomis, et al. 2008 TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4 Cell 133 1 66 77 18394990 1:CAS:528:DC%2BD1cXkslOlu7Y%3D (Pubitemid 351442989)
155. M Furuse 2010 Molecular basis of the core structure of tight junctions Cold Spring Harb Perspect Biol 2 1 a002907 20182608
156. TA Martin WG Jiang 2009 Loss of tight junction barrier function and its role in cancer metastasis Biochim Biophys Acta 1788 4 872 891 19059202 1:CAS:528:DC%2BD1MXktFahurg%3D
157. K Ebnet A Suzuki S Ohno D Vestweber 2004 Junctional adhesion molecules (JAMs): more molecules with dual functions? J Cell Sci 117 Pt 1 19 29 14657270 1:CAS:528:DC%2BD2cXks1Cks7s%3D (Pubitemid 38072117)
158. EE Schneeberger RD Lynch 2004 The tight junction: a multifunctional complex Am J Physiol Cell Physiol 286 6 C1213 C1228 15151915 1:CAS:528:DC%2BD2cXkvFCquro%3D
159. M Itoh MJ Bissell 2003 The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis J Mammary Gland Biol Neoplasia 8 4 449 462 14985640 (Pubitemid 39137506)
160. MD Lacher MI Tiirikainen EF Saunier C Christian M Anders M Oft, et al. 2006 Transforming growth factor-β receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition Cancer Res 66 3 1648 1657 16452224 1:CAS:528:DC%2BD28XpsVemsA%3D%3D (Pubitemid 43259949)
161. T Vincent EP Neve JR Johnson A Kukalev F Rojo J Albanell, et al. 2009 A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition Nat Cell Biol 11 8 943 950 19597490 1:CAS:528:DC%2BD1MXpsVaktbk%3D
162. M Grande A Franzen JO Karlsson LE Ericson NE Heldin M Nilsson 2002 Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes J Cell Sci 115 Pt 22 4227 4236 12376555 1:CAS:528:DC%2BD38XpsVyjsr8%3D (Pubitemid 35460694)
163. SR Shiou AB Singh K Moorthy PK Datta MK Washington RD Beauchamp, et al. 2007 Smad4 regulates claudin-1 expression in a transforming growth factor-β-independent manner in colon cancer cells Cancer Res 67 4 1571 1579 17308096 1:CAS:528:DC%2BD2sXhvVWqsbw%3D (Pubitemid 46383381)
164. M Barrios-Rodiles KR Brown B Ozdamar R Bose Z Liu RS Donovan, et al. 2005 High-throughput mapping of a dynamic signaling network in mammalian cells Science 307 5715 1621 1625 15761153 1:CAS:528:DC%2BD2MXitV2is7Y%3D (Pubitemid 40354744)
165. SJ Murphy JJ Dore M Edens RJ Coffey JA Barnard H Mitchell, et al. 2004 Differential trafficking of transforming growth factor-β receptors and ligand in polarized epithelial cells Mol Biol Cell 15 6 2853 2862 15075369 1:CAS:528:DC%2BD2cXks1yrtrY%3D (Pubitemid 38691873)
166. AJ Yakovich Q Huang J Du B Jiang JA Barnard 2010 Vectorial TGFβ signaling in polarized intestinal epithelial cells J Cell Physiol 224 2 398 404 20432436 1:CAS:528:DC%2BC3cXmslWitbw%3D
167. U Cavallaro G Christofori 2004 Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 4 2 118 132 14964308 1:CAS:528: DC%2BD2cXhtlaquro%3D (Pubitemid 38198740)
168. G Agiostratidou J Hulit GR Phillips RB Hazan 2007 Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression J Mammary Gland Biol Neoplasia 12 2-3 127 133 17564818 (Pubitemid 47215430)
169. K Gravdal OJ Halvorsen SA Haukaas LA Akslen 2007 A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer Clin Cancer Res 13 23 7003 7011 18056176 1:CAS:528:DC%2BD2sXhtlyitL7K (Pubitemid 350276881)
170. K Tomita A van Bokhoven GJ van Leenders ET Ruijter CF Jansen MJ Bussemakers, et al. 2000 Cadherin switching in human prostate cancer progression Cancer Res 60 13 3650 3654 10910081 1:CAS:528:DC%2BD3cXkvFChtrw%3D (Pubitemid 30482189)
171. RB Hazan GR Phillips RF Qiao L Norton SA Aaronson 2000 Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis J Cell Biol 148 4 779 790 10684258 1:CAS:528: DC%2BD3cXhsVOqsLw%3D
172. DS Micalizzi SM Farabaugh HL Ford 2010 Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression J Mammary Gland Biol Neoplasia 15 2 117 134 20490631
173. G Christofori 2003 Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression EMBO J 22 10 2318 2323 12743026 1:CAS:528:DC%2BD3sXjvV2gsL8%3D (Pubitemid 36604971)
174. KK Kim Y Wei C Szekeres MC Kugler PJ Wolters ML Hill, et al. 2009 Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis J Clin Invest 119 1 213 224 19104148 1:CAS:528:DC%2BD1MXmtFCgtw%3D%3D
175. Y Kim MC Kugler Y Wei KK Kim X Li AN Brumwell, et al. 2009 Integrin α3β1-dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts J Cell Biol 184 2 309 322 19171760 1:CAS:528:DC%2BD1MXhs1Sjsbw%3D
176. YC Tian AO Phillips 2002 Interaction between the transforming growth factor-βtype II receptor/Smad pathway and β-catenin during transforming growth factor-β1-mediated adherens junction disassembly Am J Pathol 160 5 1619 1628 12000714 1:CAS:528:DC%2BD38XksVKrtLs%3D (Pubitemid 34525642)
177. R Vogelmann MD Nguyen-Tat K Giehl G Adler D Wedlich A Menke 2005 TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN J Cell Sci 118 Pt 20 4901 4912 16219695 1:CAS:528:DC%2BD2MXht1CnurrE (Pubitemid 41646396)
178. NA Bhowmick A Chytil D Plieth AE Gorska N Dumont S Shappell, et al. 2004 TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 5659 848 851 14764882 1:CAS:528: DC%2BD2cXovVKmtQ%3D%3D (Pubitemid 38174665)
179. BG Kim C Li W Qiao M Mamura B Kasprzak M Anver, et al. 2006 Smad4 signalling in T cells is required for suppression of gastrointestinal cancer Nature 441 7096 1015 1019 16791201 1:CAS:528:DC%2BD28XmtVSnsrc%3D (Pubitemid 43980359)
180. N Cheng NA Bhowmick A Chytil AE Gorksa KA Brown R Muraoka, et al. 2005 Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks Oncogene 24 32 5053 5068 15856015 1:CAS:528: DC%2BD2MXmsFKrur4%3D (Pubitemid 41129083)
181. NA Bhowmick EG Neilson HL Moses 2004 Stromal fibroblasts in cancer initiation and progression Nature 432 7015 332 337 15549095 1:CAS:528: DC%2BD2cXpvVCjtLw%3D (Pubitemid 39551661)
182. RA Ignotz J Massague 1986 Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix J Biol Chem 261 9 4337 4345 3456347 1:CAS:528: DyaL28Xhs1amur4%3D (Pubitemid 17198877)
183. D Barkan H Kleinman JL Simmons H Asmussen AK Kamaraju MJ Hoenorhoff, et al. 2008 Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton Cancer Res 68 15 6241 6250 18676848 1:CAS:528:DC%2BD1cXpt1Wjs7w%3D
184. S Maschler G Wirl H Spring DV Bredow I Sordat H Beug, et al. 2005 Tumor cell invasiveness correlates with changes in integrin expression and localization Oncogene 24 12 2032 2041 15688013 1:CAS:528:DC%2BD2MXitlCmsrc%3D (Pubitemid 40516196)
185. J Wels RN Kaplan S Rafii D Lyden 2008 Migratory neighbors and distant invaders: tumor-associated niche cells Genes Dev 22 5 559 574 18316475 1:CAS:528:DC%2BD1cXjsVKnt7s%3D (Pubitemid 351342429)
186. EM Chandler MP Saunders CJ Yoon D Gourdon C Fischbach 2011 Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors Phys Biol 8 1 015008 21301062 1:STN:280:DC%2BC3M3jt1KisA%3D%3D
187. D Barkan LH El Touny AM Michalowski JA Smith I Chu AS Davis, et al. 2010 Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment Cancer Res 70 14 5706 5716 20570886 1:CAS:528:DC%2BC3cXovVantbo%3D
188. G Bianchini Y Qi RH Alvarez T Iwamoto C Coutant NK Ibrahim, et al. 2010 Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers J Clin Oncol 28 28 4316 4323 20805453
189. D Wienke GC Davies DA Johnson J Sturge MB Lambros K Savage, et al. 2007 The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo Cancer Res 67 21 10230 10240 17974964 1:CAS:528:DC%2BD2sXht1erur%2FJ (Pubitemid 350070796)
190. DP Bartel 2009 MicroRNAs: target recognition and regulatory functions Cell 136 2 215 233 19167326 1:CAS:528:DC%2BD1MXhs1Kiuro%3D
191. GA Calin C Sevignani CD Dumitru T Hyslop E Noch S Yendamuri, et al. 2004 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc Natl Acad Sci USA 101 9 2999 3004 14973191 1:CAS:528:DC%2BD2cXitlWhtr8%3D (Pubitemid 38327724)
192. Smeets A, Daemen A, Vanden Bempt I, Gevaert O, Claes B, Wildiers H, et al. Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs. Breast Cancer Res Treat. 2010: PMID: 21116709.
193. MV Iorio M Ferracin CG Liu A Veronese R Spizzo S Sabbioni, et al. 2005 MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 16 7065 7070 16103053 1:CAS:528:DC%2BD2MXns1WrtL8%3D (Pubitemid 41161233)
194. S Volinia GA Calin CG Liu S Ambs A Cimmino F Petrocca, et al. 2006 A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci USA 103 7 2257 2261 16461460 1:CAS:528:DC%2BD28XhslGjsbg%3D (Pubitemid 43271657)
195. Q Huang K Gumireddy M Schrier C le Sage R Nagel S Nair, et al. 2008 The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis Nat Cell Biol 10 2 202 210 18193036 1:CAS:528:DC%2BD1cXhs1Kiurk%3D (Pubitemid 351194050)
196. L Ma J Teruya-Feldstein RA Weinberg 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 7163 682 688 17898713 1:CAS:528:DC%2BD2sXhtFChurfF (Pubitemid 47552092)
197. S Zhu H Wu F Wu D Nie S Sheng YY Mo 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Res 18 3 350 359 18270520 1:CAS:528:DC%2BD1cXivVyjsb8%3D (Pubitemid 351333899)
198. SF Tavazoie C Alarcon T Oskarsson D Padua Q Wang PD Bos, et al. 2008 Endogenous human microRNAs that suppress breast cancer metastasis Nature 451 7175 147 152 18185580 1:CAS:528:DC%2BD1cXksVGhuw%3D%3D
199. PA Gregory AG Bert EL Paterson SC Barry A Tsykin G Farshid, et al. 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 5 593 601 18376396 1:CAS:528: DC%2BD1cXltl2is7c%3D (Pubitemid 351627379)
200. J Zavadil M Narasimhan M Blumenberg RJ Schneider 2007 Transforming growth factor-β and microRNA:mRNA regulatory networks in epithelial plasticity Cells Tissues Organs 185 1-3 157 161 17587821 1:CAS:528:DC%2BD2sXmvFSnurc%3D (Pubitemid 46956856)
201. S Zhu ML Si H Wu YY Mo 2007 MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) J Biol Chem 282 19 14328 14336 17363372 1:CAS:528:DC%2BD2sXkvVynsLk%3D (Pubitemid 47100416)
202. B Qian D Katsaros L Lu M Preti A Durando R Arisio, et al. 2009 High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGFβ1 Breast Cancer Res Treat 117 1 131 140 18932017 1:CAS:528:DC%2BD1MXpvFyiur8%3D
203. BN Davis AC Hilyard G Lagna A Hata 2008 SMAD proteins control DROSHA-mediated microRNA maturation Nature 454 7200 56 61 18548003 1:CAS:528:DC%2BD1cXotVertbo%3D (Pubitemid 351931982)
204. A Singh J Settleman 2010 EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 34 4741 4751 20531305 1:CAS:528:DC%2BC3cXntVSrur0%3D
205. R Pardal MF Clarke SJ Morrison 2003 Applying the principles of stem-cell biology to cancer Nat Rev Cancer 3 12 895 902 14737120 1:CAS:528: DC%2BD3sXpvFahs7o%3D (Pubitemid 37500174)
206. PB Gupta CL Chaffer RA Weinberg 2009 Cancer stem cells: mirage or reality? Nat Med 15 9 1010 1012 19734877 1:CAS:528:DC%2BD1MXhtV2gsb%2FM
207. BB Zhou H Zhang M Damelin KG Geles JC Grindley PB Dirks 2009 Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Nat Rev Drug Discov 8 10 806 823 19794444 1:CAS:528:DC%2BD1MXhtF2kurbL
208. K Polyak RA Weinberg 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 4 265 273 19262571 1:CAS:528:DC%2BD1MXis1Chtb0%3D
209. M Al-Hajj MS Wicha A Benito-Hernandez SJ Morrison MF Clarke 2003 Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100 7 3983 3988 12629218 1:CAS:528:DC%2BD3sXivFSqtbs%3D (Pubitemid 36418143)
210. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 7 730 737 9212098 1:CAS:528:DyaK2sXkt1GrtLY%3D (Pubitemid 27298715)
211. K Takahashi S Yamanaka 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 4 663 676 16904174 1:CAS:528:DC%2BD28Xpt1aktbs%3D (Pubitemid 44233629)
212. J Yu MA Vodyanik K Smuga-Otto J Antosiewicz-Bourget JL Frane S Tian, et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells Science 318 5858 1917 1920 18029452 1:CAS:528:DC%2BD2sXhsVGjsLbN
213. JP Thiery H Acloque RY Huang MA Nieto 2009 Epithelial-mesenchymal transitions in development and disease Cell 139 5 871 890 19945376 1:CAS:528:DC%2BC3cXksFWltA%3D%3D
214. MF Pera PP Tam 2010 Extrinsic regulation of pluripotent stem cells Nature 465 7299 713 720 20535200 1:CAS:528:DC%2BC3cXntF2nu70%3D
215. M Stadtfeld K Hochedlinger 2010 Induced pluripotency: history, mechanisms, and applications Genes Dev 24 20 2239 2263 20952534 1:CAS:528:DC%2BC3cXhtlyqt7rI
216. B Greber H Lehrach J Adjaye 2007 Fibroblast growth factor 2 modulates transforming growth factor βsignaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC self-renewal Stem Cells 25 2 455 464 17038665 1:CAS:528:DC%2BD2sXivVOlt7g%3D (Pubitemid 46232801)
217. D James AJ Levine D Besser A Hemmati-Brivanlou 2005 TGFβ/activin/ nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells Development 132 6 1273 1282 15703277 1:CAS:528: DC%2BD2MXjsFentLs%3D (Pubitemid 40528787)
218. U Wellner J Schubert UC Burk O Schmalhofer F Zhu A Sonntag, et al. 2009 The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs Nat Cell Biol 11 12 1487 1495 19935649 1:CAS:528:DC%2BD1MXhsV2gsLnM
219. HX Li M Han M Bernier B Zheng SG Sun M Su, et al. 2010 Kruppel-like factor 4 promotes differentiation by transforming growth factor-βreceptor- mediated Smad and p38 MAPK signaling in vascular smooth muscle cells J Biol Chem 285 23 17846 17856 20375011 1:CAS:528:DC%2BC3cXmslSmsLY%3D
220. VJ Wielenga R Smits V Korinek L Smit M Kielman R Fodde, et al. 1999 Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway Am J Pathol 154 2 515 523 10027409 1:CAS:528:DyaK1MXjtVCqtrs%3D (Pubitemid 29094101)
221. CN Bennett JE Green 2008 Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models Breast Cancer Res 10 5 213 18828875
222. CJ Aslakson FR Miller 1992 Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 52 6 1399 1405 1540948 1:STN:280:DyaK387nsVWmsA%3D%3D
223. SJ Santner PJ Dawson L Tait HD Soule J Eliason AN Mohamed, et al. 2001 Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells Breast Cancer Res Treat 65 2 101 110 11261825 1:STN:280: DC%2BD3M7mtVWitA%3D%3D (Pubitemid 32193613)
224. JW Rak D McEachern FR Miller 1992 Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia Br J Cancer 65 5 641 648 1586590 1:CAS:528:DyaK38Xks1Olsrg%3D
225. T Tsuji S Ibaragi K Shima MG Hu M Katsurano A Sasaki, et al. 2008 Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth Cancer Res 68 24 10377 10386 19074907 1:CAS:528:DC%2BD1cXhsV2itLzN
226. SS McAllister AM Gifford AL Greiner SP Kelleher MP Saelzler TA Ince, et al. 2008 Systemic endocrine instigation of indolent tumor growth requires osteopontin Cell 133 6 994 1005 18555776 1:CAS:528:DC%2BD1cXnsF2gtb0%3D (Pubitemid 351787747)
227. MY Kim T Oskarsson S Acharyya DX Nguyen XH Zhang L Norton, et al. 2009 Tumor self-seeding by circulating cancer cells Cell 139 7 1315 1326 20064377
228. M Nomura E Li 1998 Smad2 role in mesoderm formation, left-right patterning and craniofacial development Nature 393 6687 786 790 9655392 1:CAS:528:DyaK1cXktlyrur8%3D (Pubitemid 28299489)
229. WR Waldrip EK Bikoff PA Hoodless JL Wrana EJ Robertson 1998 Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo Cell 92 6 797 808 9529255 1:CAS:528:DyaK1cXit1KlsLY%3D (Pubitemid 28155318)
230. Y Zhu JA Richardson LF Parada JM Graff 1998 Smad3 mutant mice develop metastatic colorectal cancer Cell 94 6 703 714 9753318 1:CAS:528: DyaK1cXmtlCjs70%3D (Pubitemid 28436003)
231. MB Datto JP Frederick L Pan AJ Borton Y Zhuang XF Wang 1999 Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction Mol Cell Biol 19 4 2495 2504 10082515 1:CAS:528:DyaK1MXit1ams7w%3D (Pubitemid 29144493)
232. X Yang JJ Letterio RJ Lechleider L Chen R Hayman H Gu, et al. 1999 Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β EMBO J 18 5 1280 1291 10064594 1:CAS:528:DyaK1MXhvFOktLw%3D (Pubitemid 29110312)
233. A Kretschmer K Moepert S Dames M Sternberger J Kaufmann A Klippel 2003 Differential regulation of TGF-βsignaling through Smad2, Smad3 and Smad4 Oncogene 22 43 6748 6763 14555988 1:CAS:528:DC%2BD3sXotVWnsbs%3D (Pubitemid 37372215)
234. J Dzwonek O Preobrazhenska S Cazzola A Conidi A Schellens M van Dinther, et al. 2009 Smad3 is a key nonredundant mediator of transforming growth factor βsignaling in Nme mouse mammary epithelial cells Mol Cancer Res 7 8 1342 1353 19671686 1:CAS:528:DC%2BD1MXhtVWrsL%2FF
235. E Piek WJ Ju J Heyer D Escalante-Alcalde CL Stewart M Weinstein, et al. 2001 Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts J Biol Chem 276 23 19945 19953 11262418 1:CAS:528:DC%2BD3MXktlKgu7g%3D
236. KA Brown JA Pietenpol HL Moses 2007 A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-β signaling J Cell Biochem 101 1 9 33 17340614 1:CAS:528:DC%2BD2sXkvFekur8%3D (Pubitemid 46652569)
237. M Petersen E Pardali G van der Horst H Cheung C van den Hoogen G van der Pluijm, et al. 2010 Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis Oncogene 29 9 1351 1361 20010874 1:CAS:528:DC%2BD1MXhsFGmsLvF
238. F Tian S DaCosta Byfield WT Parks S Yoo A Felici B Tang, et al. 2003 Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines Cancer Res 63 23 8284 8292 14678987 1:CAS:528:DC%2BD3sXpvVagt7Y%3D (Pubitemid 37549480)
239. B Tang M Vu T Booker SJ Santner FR Miller MR Anver, et al. 2003 TGF-βswitches from tumor suppressor to prometastatic factor in a model of breast cancer progression J Clin Invest 112 7 1116 1124 14523048 1:CAS:528:DC%2BD3sXnvFGrsbo%3D (Pubitemid 38056326)
240. F Tian SD Byfield WT Parks CH Stuelten D Nemani YE Zhang, et al. 2004 Smad-binding defective mutant of transforming growth factor β type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines Cancer Res 64 13 4523 4530 15231662 1:CAS:528:DC%2BD2cXltlOrsLk%3D (Pubitemid 38856924)
241. M Korpal J Yan X Lu S Xu DA Lerit Y Kang 2009 Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis Nat Med 15 8 960 966 19597504 1:CAS:528:DC%2BD1MXosFWhtr0%3D
242. S Giampieri C Manning S Hooper L Jones CS Hill E Sahai 2009 Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility Nat Cell Biol 11 11 1287 1296 19838175 1:CAS:528: DC%2BD1MXhtlCnu7rN
243. S Giampieri S Pinner E Sahai 2010 Intravital imaging illuminates transforming growth factor β signaling switches during metastasis Cancer Res 70 9 3435 3439 20424121 1:CAS:528:DC%2BC3cXltlegu70%3D
244. DT Butcher T Alliston VM Weaver 2009 A tense situation: forcing tumour progression Nat Rev Cancer 9 2 108 122 19165226 1:CAS:528:DC%2BD1MXpsVeqtA%3D%3D
245. MJ Paszek VM Weaver 2004 The tension mounts: mechanics meets morphogenesis and malignancy J Mammary Gland Biol Neoplasia 9 4 325 342 15838603 (Pubitemid 41149140)
246. S Kumar VM Weaver 2009 Mechanics, malignancy, and metastasis: the force journey of a tumor cell Cancer Metastasis Rev 28 1-2 113 127 19153673
247. KN Sugahara T Teesalu PP Karmali VR Kotamraju L Agemy OM Girard, et al. 2009 Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 16 6 510 520 19962669 1:CAS:528:DC%2BC3cXht1eqsbY%3D
248. J Kota RR Chivukula KA O'Donnell EA Wentzel CL Montgomery HW Hwang, et al. 2009 Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 137 6 1005 1017 19524505 1:CAS:528:DC%2BD1MXps1eiurg%3D
249. N Tsuda S Ishiyama Y Li CG Ioannides JL Abbruzzese DZ Chang 2006 Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells Clin Cancer Res 12 21 6557 6564 17085671 1:CAS:528:DC%2BD28XhtFKitbjO (Pubitemid 44799731)
250. A Bhardwaj S Singh AP Singh 2010 MicroRNA-based cancer therapeutics: big hope from small RNAs Mol Cell Pharmacol 2 5 213 219 21289871 1:CAS:528:DC%2BC3MXivFGnsL8%3D
251. J Weiler J Hunziker J Hall 2006 Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther 13 6 496 502 16195701 1:CAS:528:DC%2BD28XitVGnurg%3D
252. J Krutzfeldt N Rajewsky R Braich KG Rajeev T Tuschl M Manoharan, et al. 2005 Silencing of microRNAs in vivo with 'antagomirs' Nature 438 7068 685 689 16258535
253. K Gumireddy DD Young X Xiong JB Hogenesch Q Huang A Deiters 2008 Small-molecule inhibitors of microrna miR-21 function Angew Chem Int Ed Engl 47 39 7482 7484 18712719 1:CAS:528:DC%2BD1cXht1Sjur7I
254. MS Ebert JR Neilson PA Sharp 2007 MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nat Methods 4 9 721 726 17694064 1:CAS:528:DC%2BD2sXps12gsbo%3D (Pubitemid 47338166)